PEP
33
4
ZTS
38
4
LMT
29
-5
SJM
17
5
IR
46
3
AXP
63
3
JNPR
59
3
EA
41
3
PLD
35
5
ADI
54
4
VIX
41
-11
DRI
74
5
PNW
55
3
D
32
10
AON
25
4
HP
44
14
MDT
59
4
CCI
30
2
PCG
59
9
JPM
59
6
PEP
33
4
ZTS
38
4
LMT
29
-5
SJM
17
5
IR
46
3
AXP
63
3
JNPR
59
3
EA
41
3
PLD
35
5
ADI
54
4
VIX
41
-11
DRI
74
5
PNW
55
3
D
32
10
AON
25
4
HP
44
14
MDT
59
4
CCI
30
2
PCG
59
9
JPM
59
6
Financhill
Back

Atara Biotherapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
37

ATRA
Atara Biotherapeutics

Last Price:
$11.27
Seasonality Move:
4.11%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
37
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy, Sell or Hold?

  • The current Atara Biotherapeutics [ATRA] share price is $11.40. The Score for ATRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ATRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATRA Stock Price Chart

What is Atara Biotherapeutics's stock price today?

  • The Atara Biotherapeutics share price today is $11.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

ATRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 51.71 Buy
Chaikin Money Flow: 138596 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.63 - 12.55) Sell
Bollinger Bands (100): (7.42 - 11.18) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.71 - 15.03) Sell

ATRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.65 Buy
20-day SMA: 11.71 Sell
50-day SMA: 10.72 Buy
200-day SMA: 11.74 Sell
8-day EMA: 10.84 Buy
20-day EMA: 11.22 Buy
50-day EMA: 10.77 Buy
200-day EMA: 14.19 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.97 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.02 Sell

Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $61.17 per share, and a decrease next year of $10.45 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Atara Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):